Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

Discover how the right fruits can supercharge your weight loss journey. Backed by science and expert advice, these fruits not ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Eli Lilly & Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative. The trial is ...

Led by the renowned bariatric surgeon Dr. Amit Taggar, the family-owned practice marks one year of patient-centered, advanced weight loss surgery in Tampa, FL. At TWLI, patients are treated like ...

Novo Nordisk’s experimental weekly shot CagriSema was shown to lead to less dramatic weight loss compared to rival Lilly’s Tirzepatide, the drug behind Zepbound and Mounjaro, in an 84-week trial, Novo ...

Drinking Water to Lose Weight: What’s the Idea? You've probably heard many of the ways water is good for you – it helps move waste out of your body, helps your cells work the way they should, ...

It's not uncommon to see initial success in your weight loss journey, only to hit a plateau later on. To combat this, a popular weight loss coach with a whopping 545,000 followers on TikTok has ...

Novo Nordisk agreed to collaborate with Replicate Biosciences to develop potential new treatments for obesity, type 2 diabetes and other cardiometabolic diseases, as it grapples with mounting ...

If you find that you’re not losing weight on Ozempic or other GLP-1 medications, your metabolism, or how quickly your body burns calories, may be the cause. It’s sometimes called the “Ozempic plateau, ...

GLP-1 receptor agonists (GLP-1 RAs) produced meaningful weight loss in patients with cirrhosis. Although those with compensated disease did not face notable muscle loss, those with decompensated ...